• 1. Fe3O4 nanoclusters highly dispersed on a porous graphene support as an additive for improving the hydrogen storage properties of LiBH4?
  Guang Xu,Wei Zhang,Ying Zhang,Xiaoxia Zhao,Ping Wen,Di Ma RSC Adv., 2018,8, 19353-19361
• 2. Fe3O4@PANI: a magnetic polyaniline nanomaterial for highly efficient and handy enrichment of intact N-glycopeptides??
  Zhizhen Lai,Mo Zhang,Jinyu Zhou,Tianjing Chen,Dan Li,Xuejing Shen,Jia Liu,Jiang Zhou,Zhili Li Analyst, 2021,146, 4261-4267
• 3. Fe3O4 nanosphere@microporous organic networks: enhanced anode performances in lithium ion batteries through carbonization?
  Byungho Lim,Jaewon Jin,Jin Yoo,Seung Yong Han,Kyeongyeol Kim,Sungah Kang,Nojin Park,Sang Moon Lee,Hae Jin Kim,Seung Uk Son Chem. Commun., 2014,50, 7723-7726
• 4. Excitonic channels from bio-inspired templated supramolecular assembly of J-aggregate nanowires?
  Daniel Messmer,Stefan Salentinig,Jakob Heier Nanoscale, 2019,11, 6929-6938
• 5. Evidence of CO2 molecule acting as an electron acceptor on a nanoporous metal–organic-framework MIL-53 or Cr3+(OH)(O2C–C6H4–CO2)?
  Alexandre Vimont,Arnaud Travert,Philippe Bazin,Jean-Claude Lavalley,Marco Daturi,Christian Serre,Gérard Férey,Sandrine Bourrelly,Philip L. Llewellyn Chem. Commun., 2007, 3291-3293

• Solvents and Organic Chemicals Organic Compounds Organic nitrogen compounds Organonitrogen compounds Aralkylamines
• Solvents and Organic Chemicals Organic Compounds Organic nitrogen compounds Organonitrogen compounds Amines Aralkylamines

Chemical Profile of (1S)-1-pyrimidin-2-ylethanamine (CAS No. 1268492-93-8)

(1S)-1-pyrimidin-2-ylethanamine, identified by its CAS number 1268492-93-8, is a significant compound in the realm of pharmaceutical and biochemical research. This chiral amine derivative has garnered attention due to its structural uniqueness and potential applications in drug development. The pyrimidine moiety, a central heterocyclic aromatic ring system, is a common structural motif in biologically active molecules, making this compound a promising candidate for further investigation.

The stereochemistry of (1S)-1-pyrimidin-2-ylethanamine is particularly noteworthy, as the (1S) configuration suggests a specific spatial arrangement of atoms that can influence its interactions with biological targets. In the context of modern drug design, such stereochemical precision is crucial for achieving optimal pharmacological activity while minimizing side effects. The compound's structure combines the versatility of the pyrimidine ring with the functional diversity of an amine group, positioning it as a versatile building block for synthetic chemists.

Recent advancements in computational chemistry have enabled more accurate predictions of the biological behavior of molecules like (1S)-1-pyrimidin-2-ylethanamine. Molecular docking studies have been employed to explore its potential binding interactions with various enzymes and receptors. These simulations have revealed that the compound exhibits favorable binding affinities with several targets relevant to therapeutic intervention, including kinases and transcription factors. Such findings underscore its potential as a lead compound in the development of novel therapeutic agents.

The synthesis of (1S)-1-pyrimidin-2-ylethanamine presents unique challenges due to its complex stereochemistry. Traditional synthetic routes often require careful optimization to ensure high enantiomeric purity. However, recent innovations in asymmetric synthesis have provided more efficient methods for constructing chiral centers. These advancements not only improve yield but also enhance scalability, making it more feasible to produce sufficient quantities for preclinical and clinical studies.

In the field of medicinal chemistry, the integration of machine learning algorithms has revolutionized the process of identifying promising drug candidates. By analyzing vast datasets of chemical structures and their biological activities, these algorithms can predict the potential efficacy of compounds like (1S)-1-pyrimidin-2-ylethanamine. This approach has accelerated the discovery pipeline, allowing researchers to focus on the most promising molecules with greater confidence.

The pyrimidine scaffold is well-documented for its role in numerous pharmacologically active compounds. Its ability to interact with biological systems through hydrogen bonding and other non-covalent interactions makes it an ideal platform for drug design. The amine group in (1S)-1-pyrimidin-2-ylethanamine further enhances its potential by providing a site for functionalization, enabling the creation of derivatives with tailored properties.

Preclinical studies have begun to explore the pharmacological profile of (1S)-1-pyrimidin-2-ylethanamine. Initial results suggest that it exhibits moderate activity against certain disease-related targets, warranting further investigation into its therapeutic potential. These studies also highlight its safety profile, indicating that it does not exhibit significant toxicity at tested doses. Such findings are encouraging for researchers looking to develop new treatments based on this compound.

The future direction of research on (1S)-1-pyrimidin-2-ylethanamine includes exploring its mechanism of action in greater detail. Understanding how this compound interacts with biological targets at a molecular level will provide insights into its therapeutic effects and help guide subsequent modifications for improved efficacy. Additionally, investigating its metabolic pathways will be crucial for assessing its bioavailability and potential side effects.

The development of novel pharmaceuticals relies heavily on collaboration between synthetic chemists, biologists, and clinicians. The interdisciplinary nature of this work ensures that compounds like (1S)-1-pyrimidin-2-ylethanamine are not only synthesized efficiently but also validated for their clinical utility. As research continues to evolve, it is expected that this compound will play a significant role in addressing unmet medical needs.

• 299170-49-3(1,2-Ethanediamine, 1-(2-pyrimidinyl)- (9CI))
• 1568163-63-2(2-Pyrimidinemethanamine, α,5-dimethyl-, (αS)-)
• 944906-24-5(1-(pyrimidin-2-yl)ethan-1-amine)
• 944906-27-8(1-(5-methylpyrimidin-2-yl)ethanamine)
• 1339236-24-6(2-pyrimidin-2-ylpropan-2-amine)
• 1183440-83-6(2-Pyrimidinemethanamine, alpha-ethyl-)
• 1159878-06-4(1-(pyrimidin-2-yl)cyclopropan-1-amine)
• 1616809-52-9(1-pyrimidin-2-ylethanamine;hydrochloride)
• 2138337-19-4(1-(pyrimidin-2-yl)ethan-1-amine dihydrochloride)
• 2095456-37-2((1S)-1-pyrimidin-2-ylethanamine;hydrochloride)